Form 4: Avanos Medical CEO Joseph Woody Reports Share Transactions
SEC Form 4 Filing
CEO Joseph Woody reports acquisition of restricted share units and disposition of shares to cover tax obligations.
Summary
- On March 6, 2024, Joseph Fralin Woody, CEO of Avanos Medical, Inc., acquired 137,147 time-based restricted share units (TRSUs) under the company's 2021 Long Term Incentive Plan.
- These TRSUs will vest in three equal installments on March 6, 2025, March 6, 2026, and March 6, 2027.
- Woody also disposed of 8,868 shares of common stock on March 6, 2024, at a price of $19 per share to satisfy tax withholding obligations related to the vesting of TRSUs awarded on March 6, 2023.
- Following these transactions, Woody beneficially owns 437,989 shares of Avanos Medical, Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it reflects routine insider transactions related to compensation. There are no explicit positive or negative implications for the company's performance.
Positives
- The acquisition of TRSUs demonstrates continued alignment of the CEO's interests with the long-term performance of the company.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the TRSUs.
Industry Context
This filing is a routine disclosure of insider transactions, which are common for executives receiving equity-based compensation. It provides transparency to investors regarding the holdings and transactions of company insiders.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies and their executives.
- The vesting schedule of the TRSUs is typical for long-term incentive plans.
Stakeholder Impact
- The transactions have a minor impact on shareholders by providing transparency into executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 03/06/2023 | Date of original TRSU award, of which 1/3 vested on March 6, 2024 |
| 06/30/2023 | Date of acquisition of 922 shares under the Employee Stock Purchase Plan. |
| 03/06/2024 | Date of TRSU acquisition and share disposition for tax obligations. |
| 03/06/2025 | Vesting date for 1/3 of the TRSUs awarded on March 6, 2024. |
| 03/06/2026 | Vesting date for 1/3 of the TRSUs awarded on March 6, 2024. |
| 03/06/2027 | Vesting date for 1/3 of the TRSUs awarded on March 6, 2024. |
| 03/07/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.